Crohn's Disease Activity Index (CDAI)

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۲۰۰ • واحد: count

حداقل ۱۰ — حداکثر ۶۰ • واحد: percentage

حداقل ۳۰ — حداکثر ۳۰۰ • واحد: kg

حداقل ۳۰ — حداکثر ۳۰۰ • واحد: kg

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
cdai score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Remission0–149
  • Mild Disease150–219
  • Moderate Disease220–299
  • Severe Disease300–450
Direct Clinical Answer

The Crohn's Disease Activity Index (CDAI) calculates assessing gastrointestinal disease severity, endoscopic intervention urgency, and rebleeding risk. Key inputs include liquid stools week. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Quantifies disease activity in Crohn's disease patients using clinical symptoms and laboratory findings over a 7-day period

Clinical Indication

The Crohn's Disease Activity Index (CDAI) is indicated for bedside clinical practice to support Quantifies disease activity in Crohn's disease patients using clinical symptoms and laboratory findings over a 7-day period. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.

Limitations & Contraindications

Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration.

Clinical Pearls & Action Plan

Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy. Guideline pearl: A decrease of ≥70 points is considered a significant response to treatment.

Formula & Variables:

CDAI = (Liquid stools × 2) + (Abdominal pain × 5) + (General well-being × 7) + (Extraintestinal complications × 20) + (Antidiarrheal use × 30) + (Abdominal mass × 10) + (Hematocrit deficit × 6) + (Weight deficit × 1)

Input Parameters

NameTypeRequiredDescription
liquid_stools_weekintegerYesTotal number of liquid or loose stools over the past 7 days (patient diary)(count)
abdominal_pain_scorestringYesAverage daily abdominal pain rating over the past 7 days (0=none, 1=mild, 2=moderate, 3=severe)(score)
general_wellbeing_scorestringYesAverage daily general well-being rating over the past 7 days (0=generally well, 1=slightly under par, 2=poor, 3=very poor, 4=terrible)(score)
arthritis_arthralgiasstringYesPresence of arthritis or arthralgias (joint pain/inflammation)(presence)
iritis_uveitisstringYesPresence of iritis or uveitis (eye inflammation)(presence)
erythema_nodosumstringYesPresence of erythema nodosum (skin inflammation)(presence)
anal_fissure_fistulastringYesPresence of anal fissure, fistula, or abscess(presence)
other_fistulasstringYesPresence of other fistulas (excluding anal)(presence)
feverstringYesFever >37.8°C (100°F) during the past 7 days(presence)
antidiarrheal_usestringYesUse of antidiarrheal medications (loperamide, diphenoxylate) during the past 7 days(presence)
abdominal_massstringYesPresence of abdominal mass on physical examination (0=none, 2=questionable, 5=definite)(presence)
patient_sexstringYesPatient biological sex (for expected hematocrit calculation)(sex)
observed_hematocritfloatYesCurrent hematocrit percentage (laboratory value)(percentage)
current_weightfloatYesCurrent body weight in kilograms(kg)
ideal_weightfloatYesIdeal body weight in kilograms (calculated or estimated)(kg)

Score Interpretation & Guidance

RangeStageDescription
0–149RemissionClinical remission
150–219Mild DiseaseMild disease activity
220–299Moderate DiseaseModerate disease activity
300–450Severe DiseaseSevere disease activity
451–600Very Severe DiseaseVery severe disease activity

Evidence-Based References (EBM)

  • Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70(3):439-444.
  • Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology. 2002;122(2):512-530.
  • Jørgensen LG, Fredholm L, Hyltoft Petersen P, et al. How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)? Clin Chem Lab Med. 2005;43(4):403-411.

Related calculators